Old Web
English
Sign In
Acemap
>
Paper
>
バリシチニブ(JAK1/2阻害薬)の臨床試験成績-アトピー性皮膚炎の新規経口治療薬-
バリシチニブ(JAK1/2阻害薬)の臨床試験成績-アトピー性皮膚炎の新規経口治療薬-
2021
hidemiti kou
tunemi yuuitirou
isaka kei takasi
nisikawa atusi tugu
itakura yosie
kaba sima kenzi
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]